
Asset manager
Casdin Capital
New York-based investment firm focused on the life sciences, spanning healthcare, biotechnology, synthetic biology and data technology. It builds positions in companies and partners with them over the long term.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is Casdin Capital right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
Rounds Casdin Capital joined, from press and the firm’s own posts.
Every round Casdin Capital joined
Round sizes, Casdin Capital’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company Casdin Capital backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet Casdin Capital
Events where Casdin Capital’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
Casdin Capital is based in New York, United States.
5 fund vehicles are on public registers (SEC adviser filings), including CASDIN PARTNERS MASTER FUND, L.P., CASDIN PRIVATE GROWTH EQUITY FUND II, L.P. and CASDIN PRIVATE GROWTH EQUITY FUND, L.P.
Sectors: Biotech, Life sciences, Food and agtech. From the firm’s own website.
Backs companies that apply the growing ability to read and manipulate molecular information, across healthcare, biotech, synthetic biology and technology. Targets large markets, strong ideas and teams, with patience, discipline and a multi-year view. From the firm’s own website.
Casdin Capital lists 10 portfolio companies on its website, including 23andMe, 4D Molecular Therapeutics, 908 devices, A2 Biotherapeutics and AbSci.
Firms whose websites list some of the same companies include ARCH Venture Partners, AWESOME ENABLERS, L.L.C. and Biomatics Capital.
Know before Casdin Capital’s next round is announced.
PRO tracks Casdin Capital’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.